Kutschka, Ilona
Bertero, Edoardo
Wasmus, Christina
Xiao, Ke
Yang, Lifeng
Chen, Xinyu
Oshima, Yasuhiro
Fischer, Marcus
Erk, Manuela
Arslan, Berkan
Alhasan, Lin
Grosser, Daria
Ermer, Katharina J.
Nickel, Alexander
Kohlhaas, Michael
Eberl, Hanna
Rebs, Sabine
Streckfuss-Bömeke, Katrin
Schmitz, Werner
Rehling, Peter
Thum, Thomas
Higuchi, Takahiro
Rabinowitz, Joshua
Maack, Christoph
Dudek, Jan
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DU1839/2-1, Ma 2528/8-1, RTG 2824)
HORIZON EUROPE European Research Council (ERC Advanced Grant REVERSE, European Research Council (ERC) Advanced Grant (ERCAdG No. 339580))
Universitätsklinikum Würzburg
Article History
Received: 14 February 2023
Revised: 29 September 2023
Accepted: 14 October 2023
First Online: 6 November 2023
Declarations
:
: CM received speaker and consultancy honoraria from Boehringer Ingelheim, AstraZeneca and Novo Nordisk. TT is founder and shareholder of Cardior Pharmaceuticals (outside of this study). TT filed and licensed patents about the use of noncoding RNAs (outside of the paper).